4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-25-038426
Director sold 5,121 shares at an average $67.15 ($343,889)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KLAUSNER ARTHUR J Director | 2025-12-18 | Sale | −4,660 | $67.06 | $312,500 | 9,223 | D: show line 1 in the form |
| KLAUSNER ARTHUR J Director | 2025-12-18 | Sale | −461 | $68.09 | $31,389 | 8,762 | D: show line 2 in the form |
| Open-market sales · 5,121 sh · avg $67.15 · $343,889 | |||||||
Loading xslF345X05/rdgdoc.xml…